Diurnal oscillation of CSF Aβ and other AD biomarkers

To assess stages of Alzheimer's disease (AD) pathogenesis and the efficacy of drugs during clinical trials, there has been immense interest in the field to establish baseline cerebrospinal fluid (CSF) concentrations for potential AD biomarkers such as amyloid-β (Aβ) and tau. Significant within-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucey, Brendan P., Fagan, Anne M., Holtzman, David M., Morris, John C., Bateman, Randall J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421331/
https://www.ncbi.nlm.nih.gov/pubmed/28478762
http://dx.doi.org/10.1186/s13024-017-0161-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421331/
https://www.ncbi.nlm.nih.gov/pubmed/28478762
http://dx.doi.org/10.1186/s13024-017-0161-4

Ejemplares similares